Fundraising gets disproportionate attention in startup culture. It’s celebrated like an achievement, when it’s actually trading ownership for capital. Understanding this context helps you approach fundraising strategically.
•
Capital-intensive business model (hardware, biotech)
•
Market opportunity requires speed (winner-take-most)
•
Unit economics work but need scale
•
Clear use of funds with high ROI
•
Status/validation seeking
•
Can’t make payroll otherwise
•
No idea what you’d use it for
Alternatives to Venture Capital
Not every business needs VC:
Bootstrapping: Fund from revenue. Slower but you keep ownership.
Revenue-based financing: Pay back from revenue. No equity dilution.
Grants: Free money for specific purposes.
Loans/Lines of credit: Debt, not equity.
Angel investment: Less institutional, more flexible.
Crowdfunding: Community-funded (equity or reward).
VC is one path, not the only path.
•
Committing to aggressive growth
•
Narrowing exit options (need big outcome)
Understand this trade-off.
VCs raise funds from LPs (pension funds, endowments, wealthy individuals).
•
Return the fund 3x+ over 10 years
•
Invest in high-growth companies
•
Support those companies to exit (IPO or acquisition)
This model explains VC behavior.
•
Invests in 20-30 companies
•
Expects most to fail or return nothing
•
Needs a few to return 10x-100x
•
Those winners return the whole fund
VCs aren’t looking for moderate success. They need big outcomes.
•
You’re committing to chase a big outcome
•
“Nice small business” isn’t acceptable
•
Grow aggressively or shut down
•
Exit is expected (M&A or IPO)
Make sure your ambitions align.
The Fundraising Landscape
Pre-seed: First money in. Often friends/family/angels. $100K-$1M.
Seed: Proving product-market fit. $1M-$4M.
Series A: Scaling what works. $5M-$20M.
Series B+: Growth and expansion. $15M-$100M+.
Who Invests at Each Stage
What Investors Look For (By Stage)
Pre-seed: Team, idea, early signs of traction.
Seed: Product, early traction, path to PMF.
Series A: Product-market fit, repeatable sales, path to scale.
Series B: Proven model, strong growth, path to profitability.
The price at which you sell equity.
Pre-money valuation: What the company is worth before investment.
Post-money valuation: Pre-money + Investment.
Each round, existing shareholders own less.
•
Seed ($5M post-money, sell 20%): Founders at 80%
•
Series A ($20M post-money, sell 25%): Founders at 60%
•
Series B ($80M post-money, sell 20%): Founders at 48%
Plan for dilution over multiple rounds.
Valuation: How much you’re “worth.”
Liquidation preference: Who gets paid first in exit.
Anti-dilution: Protection for investors if future rounds are down.
Board seats: Who controls the company.
Pro-rata rights: Right to invest in future rounds.
Terms matter as much as valuation.
Raise when you don’t need to.
Standard guidance: Raise 18-24 months of runway.
•
Time to hit next milestones
•
Cushion for things taking longer
•
Ability to raise next round from strength
Markets affect fundraising:
•
Hot markets: Higher valuations, easier raises
•
Cold markets: Lower valuations, harder raises
You can’t control timing, but be aware of it.
Preparation (1-3 months before)
•
Get your materials ready (deck, data room)
•
Get warm introductions lined up
Active Raise (2-4 months typically)
Common Fundraising Mistakes
Highest valuation isn’t always best. Consider:
•
What happens if you don’t hit targets
Before you have a story to tell.
When you’re desperate and out of runway.
Fundraising distracts from building. Move efficiently.
Taking money from anyone who offers.
Selling too much too early.
•
Fundraising is trading ownership for capital—make sure it’s the right trade
•
VC is one option; bootstrap, debt, angels, and grants are others
•
VCs need home runs—only raise if you’re committed to big outcomes
•
Different stages attract different investors; know what they expect
•
Terms matter as much as valuation; understand what you’re agreeing to
•
Raise from strength, not desperation; 18-24 months runway is standard
•
Preparation matters: materials, introductions, practice
•
Optimize for partner fit and terms, not just highest valuation